Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Outcomes of Patients Bilaterally Implanted With the TECNIS® Symfony or TECNIS® Symfony Toric Extended Range of Vision IOL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03997890
Recruitment Status : Completed
First Posted : June 25, 2019
Last Update Posted : June 27, 2019
Sponsor:
Information provided by (Responsible Party):
Yonsei University

Brief Summary:

In With increased patients' demand for a spectacle-free lifestyle and technological advancements, cataract surgery with multifocal intraocular lens (IOL) implantation has become an effective solution for correcting presbyopia in patients who want to maintain their full range of vision.

Conventional bifocal IOLs used either refractive or diffractive optics to split the light and create 2 principal focal points, thus providing functional vision at distance and near. This simultaneous imaging principle produces a sharp image that is overlaid by a secondary blurred out-of focus image, so these IOLs inherently produce a deterioration in contrast sensitivity and unwanted photic phenomena such as glare and halos. Additionally, studies reported insufficient intermediate vision with bifocal IOLs.

There is an increasing desire for spectacle independence at intermediate distance, especially due to the increased use of computers and smartphones. Trifocal IOLs were introduced to the market in 2010 and participants provide an additional, third focal point to improve intermediate vision without compromising distance and near vision. However, participants are still vulnerable to decreased contrast sensitivity and photic phenomena due to the IOL's mechanism of splitting the light into discrete focal points.

An extended depth of focus (EDOF) technology was recently introduced with the aim to improve intermediate vision while maintaining image contrast. The diffractive echelette design, embedded on its posterior optical surface, extends the range of vision and the achromatic technology reduces corneal chromatic aberrations to enhance retinal image quality and improve contrast sensitivity. The elongated focus allows imaging in a continuous range of vision without overlapping near and far images, and therefore theoretically would provide a more consistent distance and intermediate vision with less dysphotopsia.

The aim of this study was to investigate the clinical outcome of patients bilaterally implanted with either Tecnis Symfony or Tecnis Symfony toric extended range of vision IOLs (Johnson & Johnson Vision, Santa Ana, CA, USA) in terms of visual performance at different distances, spectacle independence, photic phenomena, and patient satisfaction.


Condition or disease Intervention/treatment Phase
Cataract Procedure: Cataract surgery with binocular implantation of either Symfony (ZXR00) or Symfony toric (ZXT) IOLs Not Applicable

Detailed Description:

Enrollment period : 18 months after IRB approval Participants : Patients who had uncomplicated cataract surgery with binocular implantation of either Symfony (ZXR00) or Symfony toric (ZXT) IOLs.

Methods: The postoperative examinations were performed at 4-8 weeks, and 4-6 months postoperatively. Binocular corrected (CDVA) and uncorrected (UDVA) distance visual acuity was assessed at 4 m using a Snellen chart. Binocular uncorrected intermediate visual acuity (UIVA) at 70 cm and binocular uncorrected near visual acuity (UNVA) at 40 cm were assessed using the Rosenbaum near vision card.

A subjective questionnaire on spectacle use, photic phenomena, and satisfaction was administered to all patients. Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities. Non-directed and directed questions were used with regard to visual symptoms. Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe. Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied). Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family. Surgeons were also asked to rate their level of satisfaction on a scale from 0 to 10 in terms of the ease of manipulation and implantation of the IOL and the visual performance of the IOL.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 96 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Outcomes of Patients Bilaterally Implanted With the TECNIS® Symfony or TECNIS® Symfony Toric Extended Range of Vision IOL
Actual Study Start Date : July 13, 2016
Actual Primary Completion Date : January 18, 2018
Actual Study Completion Date : January 18, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract

Arm Intervention/treatment
Experimental: Symfony group
The subjects who underwent cataract surgery with binocular implantation of either Symfony or Symfony toric IOLs
Procedure: Cataract surgery with binocular implantation of either Symfony (ZXR00) or Symfony toric (ZXT) IOLs
After creating an initial side port incision with a 15-degree blade, 3-step clear corneal incisions were made using a 2.5 mm disposable metal blade. Sodium hyaluronate 1.0% (Healon; Abbott Medical Optics) was then injected into the anterior chamber. A continuous curvilinear capsulorrhexis, measuring 5.5 mm in diameter, was generated using a 26 gauge bent needle. After hydrodissection, phacoemulsification was done to remove nuclear fragments and aspiration of residual cortex. In all eyes, a Symfony or Symfony toric IOL was implanted in the capsular bag using a disposable implantation system. Irrigation and aspiration were performed to minimize ophthalmic viscoelastic surgical device retention at the end of surgery. The main incision and side port were sealed with stromal hydration using a balanced salt solution.




Primary Outcome Measures :
  1. Visual outcome [ Time Frame: preoperative 4-6 weeks ]
    1. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

  2. Visual outcome [ Time Frame: preoperative 4-6 weeks ]
    2. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

  3. Visual outcome [ Time Frame: preoperative 4-6 weeks ]
    3. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.

  4. Visual outcome [ Time Frame: preoperative 4-6 weeks ]
    4. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.

  5. Visual outcome [ Time Frame: preoperative 4-6 months ]
    1. Uncorrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

  6. Visual outcome [ Time Frame: preoperative 4-6 months ]
    2. Corrected Distance Vision Acuity (4 meters) in logMAR scale at each time point.

  7. Visual outcome [ Time Frame: preoperative 4-6 months ]
    3. Uncorrected Intermediate Visual Acuity (70 cm) in logMAR scale at each time point.

  8. Visual outcome [ Time Frame: preoperative 4-6 months ]
    4. Uncorrected Near Visual Acuity (40 cm) in logMAR scale at each time point.


Secondary Outcome Measures :
  1. Spectacle use [ Time Frame: Postoperative 4-6 weeks ]
    Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities.

  2. Spectacle use [ Time Frame: Postoperative 4-6 months ]
    Patients were asked how often (never, occasionally, 50% of the time, frequently) participants wear spectacles for near, intermediate, and distance activities.

  3. Photic phenomena [ Time Frame: Postoperative 4-6 weeks ]
    Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe.

  4. Photic phenomena [ Time Frame: Postoperative 4-6 months ]
    Photic phenomena (halos, glare and starbursts) were graded as none, trace, mild, moderate, or severe.

  5. Patient Satisfaction [ Time Frame: Postoperative 4-6 weeks ]
    Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied). Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family.

  6. Patient Satisfaction [ Time Frame: Postoperative 4-6 months ]
    Patients were asked to rate their level of satisfaction with distance, intermediate, and near vision on a scale from 0 (completely dissatisfied) to 10 (completely satisfied). Additionally, participants were asked whether participants would choose the same IOL again and if participants would recommend the IOL to their friends and family.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 1. Age of 20 years or older
  • 2. Cataract

Exclusion Criteria:

  • 1. Amblyopia
  • 2. Keratoconus
  • 3. Previous corneal or refractive surgery
  • 4. Chronic or recurrent uveitis
  • 5. Acute ocular disease
  • 6. Previous ocular surgeries
  • 7. Glaucoma
  • 8. Any ocular disease which could possible affect the postoperative visual acuity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03997890


Locations
Layout table for location information
Korea, Republic of
Department of Ophthalmology, Yonsei Univeristy College of Medicine
Seoul, Korea, Republic of, 03722
Sponsors and Collaborators
Yonsei University

Layout table for additonal information
Responsible Party: Yonsei University
ClinicalTrials.gov Identifier: NCT03997890     History of Changes
Other Study ID Numbers: 1-2016-0029
First Posted: June 25, 2019    Key Record Dates
Last Update Posted: June 27, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yonsei University:
Extended depth of focus
Multifocal intraocular lens
Presbyopia
Cataract surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Cataract
Lens Diseases
Eye Diseases